Business Context and Reporting Period
Company: Healthcare Realty Trust Inc (HR)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: A self-managed REIT owning, leasing, and managing income-producing real estate primarily associated with outpatient healthcare services. As of December 31, 2025, the Company held gross investments of approximately $10.3 billion in 502 consolidated properties and a 30% weighted average interest in 61 unconsolidated joint venture properties. The portfolio is 90.4% occupied.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Total Revenues | $1.18 billion | $1.27 billion |
| Net Loss (GAAP) | $(249.5) million | $(663.9) million |
| Funds from Operations (FFO) | $490.0 million | $193.3 million |
| Normalized FFO | $568.9 million | $576.8 million |
| Funds Available for Distribution (FAD) | $448.3 million | $419.1 million |
| Cash Flow from Operations | $457.1 million | $501.6 million |
| Total Debt (Principal) | $4.10 billion | $4.66 billion |
| Weighted Average Interest Rate | 4.52% | N/A |
| Dividends Declared (Per Share) | $1.10 | $1.24 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased by 7.7% ($94.7 million) primarily due to property dispositions ($130.8 million impact), partially offset by leasing activity and new developments.
- Net Loss Improvement: Net loss narrowed significantly from $(663.9) million in 2024 to $(249.5) million in 2025. The 2024 loss included a one-time $250.5 million goodwill impairment charge which did not recur in 2025.
- Impairment Charges: The Company recorded $361.1 million in real estate impairment charges in 2025 related to completed or planned dispositions and changes in holding periods, compared to $249.9 million in 2024.
- Dispositions: The Company disposed of 70 properties in 2025 for gross sales prices of approximately $1.1 billion, generating net cash proceeds of $1.0 billion. No acquisition activity occurred in 2025.
- Debt Reduction: Total principal debt decreased by approximately $550 million as the Company repaid $650 million in term loans and $250 million in senior notes maturing in 2025.
Guidance, Outlook, and Risks
- Outlook: Management expects to meet liquidity needs through cash on hand, operating cash flows, asset sales, and capital markets access. The Company continues to focus on reinvesting disposition proceeds into accretive opportunities.
- Leasing Trends: Weighted average remaining lease term is 4.4 years. Cash leasing spreads averaged 2.7% in 2025. Approximately 15% of leases expire annually.
- Key Risks:
- Prospect Medical Bankruptcy: Prospect Medical Holdings filed for Chapter 11 in January 2025. While a subsidiary of Hartford HealthCare assumed leases for 65,477 square feet effective January 2026, there is no assurance the remaining space will be relet timely.
- Regulatory Environment: Changes in Medicare/Medicaid reimbursement rates and site-neutral payment policies could impact tenant ability to pay rent. The "One Big Beautiful Bill Act of 2025" permanently extended certain tax deductions but remains subject to analysis.
- Interest Rate Sensitivity: The Company has exposure to variable rates on its credit facility and term loans, though it utilizes interest rate swaps to hedge $500 million of exposure.
- Capital Allocation: The Board authorized a $500 million share repurchase program in October 2025. In January 2026, the Company repurchased 2.9 million shares for $50 million.
Investor Verification Checklist
- Disposition Reinvestment: Verify the Company's ability to reinvest the $1.0 billion in net disposition proceeds at yields comparable to the 6.7% weighted average cap rate achieved on sales.
- Prospect Medical Exposure: Monitor the re-leasing status of the remaining Prospect Medical space not assumed by Hartford HealthCare to assess potential vacancy impacts.
- Debt Maturity Wall: Confirm refinancing plans for the $1.3 billion of debt maturing in 2026 and 2027, particularly given the current interest rate environment.
- Impairment Frequency: Review the $361.1 million in impairment charges to understand if they reflect a broader portfolio valuation adjustment or isolated asset-specific issues.
- Dividend Sustainability: Assess the coverage of the $1.10 per share dividend by FAD ($448.3 million) and the impact of the dividend reduction from $1.24 in 2024.